Emergency Medicine

HIV / AIDS

Medical News

Primary Care

Surgery

Home » Primary Care

Drug May Protect Kids After Stem Cell Transplant (CME/CE)

Submitted by on Thursday, 23 February 2012No Comment

(MedPage Today) — Prophylactic defibrotide appeared to lower the incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplant, European researchers found.

Originally posted here: 
Drug May Protect Kids After Stem Cell Transplant (CME/CE)

Found something that might interest others? Share!

You may also like:

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word